L
Power Law company profile
Lunit
Biotech & Life Sciences · Seoul, South Korea · Founded 2013 · IPO 2022 Unicorn
Valuation
$620M
Market cap · May/2026
Revenue
$70M
Latest reported FY
AI-powered medical solutions for cancer diagnostics and therapeutics
Global footprint
Where Lunit has talent and traffic
AI talent share
1.4%
of workforce is AI talent
(5 of 355 staff)
(5 of 355 staff)
Core AI30.85%
Other AI20.56%
Non-AI workforce35098.59%
Workforce by country
16
countries with
team presence
team presence
🇰🇷 South Korea71%
🇺🇸 United States11.2%
🇳🇿 New Zealand6.6%
🇫🇷 France2%
🇳🇱 Netherlands1.7%
Web traffic by country
41K
monthly visits
across markets
across markets
🏳️ Korea23.2%
🏳️ Republic of20.2%
🇺🇸 United States19.8%
🇮🇳 India6.6%
🇦🇺 Australia4.9%
Sentiment on X
What X is saying about Lunit
An AI-synthesized read of the highest-engagement posts about Lunit on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Lunit on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.